Haleon reported second-quarter organic sales growth of 3.1%, a sequential improvement from the first quarter, with volume and mix up 1.4%. North America grew 3.1% with 2% volume, helped by shelf resets, innovation, and e-commerce momentum, while emerging markets delivered 6.3% growth, led by India and Latin America. Operating margin expanded 120 basis points at constant currency, supported by supply chain efficiency and a 140-basis-point gross margin improvement. The company maintained advertising and promotion investment at 20.9% of sales, with increased digital spend. However, respiratory health remained a drag, shaving 150 basis points off organic growth, and Europe posted only 0.4% growth amid low single-digit category declines. Haleon expects a stronger second half and remains confident in its 3% to 5% full-year guidance.
Haleon PLCOrganic sales growth improved to 3.1% with volume and mix up 1.4%, driven by North America and emerging markets.